Ist baicalin in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
Pregnancy-safe products containing baicalin










Related ingredients
Frequently asked questions
- Ist baicalin in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (no H360/H361) and no SCCS/CIR safety assessment flagging reproductive hazard were identified. PubMed/PMC studies of baicalin in pregnancy models report pharmacologic/modulatory effects (some protective in LPS models) rather than consistent reproductive toxicity, so by source-priority standards there is no evidence requiring a hazard flag. Sources: PubMed/PMC animal studies and regulatory databases (PubChem/KEGG, EWG).
- Ist baicalin während des Stillens sicher?
- No regulatory or authoritative safety assessment (CIR, SCCS, harmonised CLP) indicates lactation/transfer hazards, and published studies do not provide clear evidence of adverse effects via lactation. No data found demonstrating transfer in human milk or adverse pup outcomes via lactation in relevant high-quality studies; therefore default score is 0. (See cited studies and database entries.)
- Ist baicalin sicher für Babyhaut?
- No evidence of a reproductive/developmental hazard specific to infants (h=0). Mechanistic evidence for a reproductive mechanism was not identified (m=0). For exposure (e) I increased the score by +1 for baby skin because baicalin is a small natural flavonoid glycoside with measurable biological activity in vivo (so it is not completely non‑absorbable); topical dermal absorption from cosmetics is expected to be low for the parent compound but infant skin has a higher surface‑area‑to‑weight and immature barrier, so exposure for 0–3 y is assigned 1. No infant‑specific toxicokinetic data were found to justify higher exposure or hazard scores.
- Wie bewertet VeriMom baicalin?
- VeriMom bewertet baicalin mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu baicalin?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu baicalin basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.